NICaS Technology
NI Medical’s non-invasive solution is uniquely designed to enable physicians to measure cardiac parameters in various settings, such as patients’ homes, clinics, hospitals, and ICUs. NICaS technology provides you with a personalized profile, which enables personalized treatment.
NICaS, the non-invasive hemodynamic & fluid measuring system, provides each patient with a personal hemodynamic profile – information otherwise available only in high-level hospital care.
With this information, healthcare providers are able to treat their patients better, resulting in a substantial reduction in readmission rates, thus lowering the economic, as well as clinical, burden of Heart Failure.
Our Technology was developed to improve medical outcomes, both in chronic and acute conditions, and in various clinical applications including: heart failure, hypertension, preeclampsia management, hemodialysis and dialysis, CRT optimization, hemodynamic monitoring during anesthesia and infectious disease hemodynamic management.
The technology is FDA approved, CE marked and cleared for marketing in many countries worldwide for monitoring hemodynamic parameters, including stroke volume, stroke index, heart rate, cardiac index, cardiac output, and total peripheral resistance.
In addition, it has a patent for its GGI parameter, an innovative assessment tool that is able to detect the smallest decrease of the left ventricular function.
NICaS Parameters
Number of heart beats per minute
Amount of blood pumped by Left ventricle with each heart beat
Stroke volume normalized for body surface area
Amount of blood pumped by the left ventricle per minute
Cardiac Output normalized for body surface area
Cardiac output/Body surface area
An indicator of the left ventricular function
The resistance to the flow of blood in the arterial system (“Afterload”)
The resistance to the flow of blood in the arterial system normalized for body surface area
Patient’s fluid content
Number of breaths per minute
Readmission & Hospitalization Reduction
Heart failure is responsible for 11 million physician visits each year and leads to more hospitalizations than all forms of cancer combined.
NICaS can help reduce hospitalization and readmission rates. This technology can assist in the assessment and management of CHF patients in various settings.
Related Clinical Studies
Utility of NICaS Non-Invasive Hemodynamic Monitoring in Critically Ill Patients with COVID-19
Authors: Wisam Zabeeda, Jonah Benjamin Cohen, Anat Reiner Benaim, Shiri Zarour, Yael Lichter, Idit Matot, Or Goren Conclusion: Non-invasive hemodynamic monitoring via the NICaS device
The Impact of Positive Inotropic Therapy on Hemodynamics and Organ Function in Acute Heart Failure: A Differentiated View
Authors: Juan Cheko, Nikolaos Patsalis, Julian Kreutz, Dimitar Divchev, Georgios Chatzis, Bernhard Schieffer, Birgit Markus Conclusion: Patients with acute decompensated HF benefit from positive inotropic
Comparing elective and emergency caesarean section by using bioimpedance method
Authors: Zuhal Çavuş, Ayşe Vahapoğlu, Ülkü Aygen Türkmen, Fatma Ketenci Gencer, Elif Yıldız Conclusion: Understanding normal hemodynamic values before, during, and after C/S is feasible
Noninvasive Hemodynamic Evaluation Following TAVI for Severe Aortic Stenosis
Authors: Tzlil Grinberg, Yaron Aviv, Mordehay Vaturi, Leor Perl, Maya Wiessman, Hanna Vaknin-Assa, Pablo Codner, Yaron Shapira, Ran Kornowski, Katia Orvin Conclusion: Unique short‐term adaptive
Correlation of Impedance Cardiography-Derived and Cardiac Magnetic Resonance-Derived Stroke Volumes
Authors: Pedram Hassan-Tash, Umar Ismail, Iain D C Kirkpatrick, Amir Ravandi, Davinder S Jassal, Brett Hiebert, Malek Kass, Richard A Krasuski, Ashish H Shah Conclusion:
Non-invasive hemodynamic profiling of patients undergoing hemodialysis-a multicenter observational cohort study
Authors: Keren Doenyas-Barak, Marcia H. F. G. de Abreu, Lucas E. Borges, David Pereg, Ilya Litovchik, Shmuel Fuchs and Sa’ar Minha Conclusion: Non-invasive assessment of
Contact Us
